97 related articles for article (PubMed ID: 4201877)
1. Editorial: Diphosphonate treatment in bone disease.
Fleisch H; Bonjour JP
N Engl J Med; 1973 Dec; 289(26):1419-20. PubMed ID: 4201877
[No Abstract] [Full Text] [Related]
2. Proceedings: Treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate.
de Vries HR; Bijvoet OL; Froeling PG
J Endocrinol; 1975 Mar; 64(3):51P. PubMed ID: 805820
[No Abstract] [Full Text] [Related]
3. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
De Vries HR; Bijvoet OL
Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525
[No Abstract] [Full Text] [Related]
4. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
Smith R; Russell RG; Bishop MC; Woods CG; Bishop M
Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518
[No Abstract] [Full Text] [Related]
5. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
Caniggia A; Gennari C; Guideri R; Vattimo A; Nardi P
Minerva Med; 1976 Jan; 67(1):1-15. PubMed ID: 814505
[TBL] [Abstract][Full Text] [Related]
6. Combined diphosphonate and calcitonin therapy for Paget's disease of bone.
Hosking DJ; Bijvoet OL
Calcif Tissue Res; 1976 Aug; 21 Suppl():321-6. PubMed ID: 821599
[No Abstract] [Full Text] [Related]
7. [Myositis ossificans progressiva treated with diphosphonate].
Glenting P
Ugeskr Laeger; 1976 Sep; 138(39):2362-6. PubMed ID: 823676
[No Abstract] [Full Text] [Related]
8. Diphosphonate treatment of Paget's disease of bone. A correlated metabolic, calcium kinetic and morphometric study.
Guncaga J; Lauffenburger T; Lentner C; Dambacher MA; Haas HG; Fleisch H; Olah AJ
Horm Metab Res; 1974 Jan; 6(1):62-9. PubMed ID: 4819289
[No Abstract] [Full Text] [Related]
9. [Influence of disodium etidronate (EHDP) on plasma and urinary levels of sodium and potassium in humans].
Gennari C; Orlandini GA; Nuti R; Francini G
Boll Soc Ital Biol Sper; 1975 Jul; 51(14):873-7. PubMed ID: 814911
[No Abstract] [Full Text] [Related]
10. Letter: Diphosphonate and calcitonin in Paget's disease.
Hosking DJ; Bijvoet OL
Lancet; 1976 May; 1(7966):970. PubMed ID: 57380
[No Abstract] [Full Text] [Related]
11. Letter: Disodium ethane-1-hydroxy-1, 1-diphosphonate(E.H.D.P.) in Paget's disease.
Fromm G; Schajowicz F; Mautalen CA
Lancet; 1975 Oct; 2(7936):666. PubMed ID: 52045
[No Abstract] [Full Text] [Related]
12. [Clinical, biological and histological effects of ethane-1-hydroxy 1, 1-diphosphonate (EDHP) in Paget's disease].
Meunier P; Chapuy MC; Courpron P; Vignon E; Edouard C; Bernard J
Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):699-705. PubMed ID: 817385
[TBL] [Abstract][Full Text] [Related]
13. Diphosphonates. Experimental and clinical aspects.
Russell RG; Smith R
J Bone Joint Surg Br; 1973 Feb; 55(1):66-86. PubMed ID: 4632759
[No Abstract] [Full Text] [Related]
14. Paget's disease of bone.
Krane SM
Clin Orthop Relat Res; 1977; (127):24-36. PubMed ID: 410574
[No Abstract] [Full Text] [Related]
15. Radionuclide uptake studies of bone: a quantitative method of evaluating the response of patients with Paget's disease to diphosphonate therapy.
Goldman AB; Braunstein P; Wilkinson D; Kammerman S
Radiology; 1975 Nov; 117(2):365-9. PubMed ID: 809805
[TBL] [Abstract][Full Text] [Related]
16. [Non-hormonal drug treatment in Paget's disease].
Ryckewaert A; Lemaire V; Tubiana M
Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):693-8. PubMed ID: 131365
[TBL] [Abstract][Full Text] [Related]
17. Myositis ossificans progressiva. Clinical features of eight patients and their response to treatment.
Smith R; Russell RG; Woods CG
J Bone Joint Surg Br; 1976 Feb; 58(1):48-57. PubMed ID: 818090
[TBL] [Abstract][Full Text] [Related]
18. [Biphosphonate as a therapeutic drug--experimental studies and clinical application].
Fleisch H
Ther Umsch; 1985 Jun; 42(6):366-75. PubMed ID: 3161202
[No Abstract] [Full Text] [Related]
19. Diphosphonate therapy in nephrocalcinosis.
McCredie DA; Powell HR; Rotenberg E
Br J Urol; 1976 Apr; 48(2):93-100. PubMed ID: 821572
[TBL] [Abstract][Full Text] [Related]
20. Bone tissue in Paget's disease treated by ethane-1, hydroxy-1, 1 diphosphonate (EHDP). Structure, ultrastructure, and immunocytology.
Basle MF; Rebel A; Renier JC; Audran M; Filmon R; Malkani K
Clin Orthop Relat Res; 1984 Apr; (184):281-8. PubMed ID: 6423333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
